- Investing Ideas
- /
- Peruvian Pharmaceuticals & Biotech Potentially Undervalued Companies
Peruvian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
8
Companies with a Value score of at least 3, ordered by Value score
8 companies
Merck
Market Cap: US$191.8b
Operates as a healthcare company worldwide.
MRK
US$76.87
7D
-0.2%
1Y
-41.6%
Bristol-Myers Squibb
Market Cap: US$95.6b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
US$47.50
7D
0%
1Y
7.7%
Pfizer
Market Cap: US$133.3b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
US$23.40
7D
2.1%
1Y
-20.7%
Regeneron Pharmaceuticals
Market Cap: US$62.5b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
REGN
US$680.10
7D
0%
1Y
n/a
Gilead Sciences
Market Cap: US$134.9b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$110.25
7D
0%
1Y
45.4%
Johnson & Johnson
Market Cap: US$366.8b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
US$156.00
7D
0%
1Y
8.0%
Amgen
Market Cap: US$149.7b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$264.80
7D
0%
1Y
n/a
Thermo Fisher Scientific
Market Cap: US$151.8b
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
TMO
US$402.00
7D
0.6%
1Y
-31.3%